New research into the UK life sciences landscape has revealed a growing trend of investment into more mature companies.   Pioneer Group’s ‘Life Science Start Up Report’ also highlights a persistent regional imbalance, with ‘Golden Triangle’ university spinouts attracting significantly more funding than those elsewhere.  Whilst the number of deals in 2024 decreased slightly compared to […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!